A Comanche Co. woman has pleaded guilty to charges of first-degree manslaughter and child abuse in the death of her 3-year-old daughter.

Sugemalimab is the world's first anti-PD-L1 monoclonal antibody approved for the treatment of gastric or gastroesophageal junction (G/GEJ) adenocarcinoma. The GEMSTONE-303 study results support ...